• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合使用传统和基质来源的肿瘤标志物诊断胰腺导管腺癌

Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinoma.

作者信息

Franklin Oskar, Öhlund Daniel, Lundin Christina, Öman Mikael, Naredi Peter, Wang Wanzhong, Sund Malin

机构信息

Department of Surgical and Perioperative Sciences, Umeå, Sweden.

Department of Pathology, Umeå University, Umeå, Sweden.

出版信息

Cancer Biomark. 2015;15(1):1-10. doi: 10.3233/CBM-140430.

DOI:10.3233/CBM-140430
PMID:25524936
Abstract

BACKGROUND

A lack of disease-specific symptoms and good tumour markers makes early detection and diagnosis of pancreatic ductal adenocarcinoma (PDAC) challenging.

OBJECTIVE

To analyse the tissue expression and circulating levels of four stroma-derived substances (type IV collagen, endostatin/type XVIII collagen, osteopontin and tenascin C) and four conventional tumour markers (CA 19-9, TPS, CEA and Ca 125) in a PDAC cohort.

METHODS

Tissue expression of markers in normal pancreas and PDAC tissue was analysed with immunofluorescence. Plasma concentrations of markers were measured before and after surgery. Patients with non-malignant disorders served as controls.

RESULTS

The conventional and stromal substances were expressed in the cancer cell compartment and the stroma, respectively. Although most patients had increased levels of many markers before surgery, 2/12 (17%) of patients had normal levels of Ca 19-9 at this stage. High preoperative endostatin/type XVIII collagen, and postoperative type IV collagen was associated with short survival. Neither the pre- nor postoperative levels of TPS, Ca 125 or CA 19-9 were associated to survival.

CONCLUSIONS

PDAC is characterized by an abundant stroma. These initial observations indicate that the stroma can be a source of PDAC tumour markers that are found in different compartments of the cancer, thus reflecting different aspects of tumour biology.

摘要

背景

缺乏疾病特异性症状和良好的肿瘤标志物使得胰腺导管腺癌(PDAC)的早期检测和诊断具有挑战性。

目的

分析胰腺导管腺癌队列中四种基质衍生物质(IV型胶原、内皮抑素/ XVIII型胶原、骨桥蛋白和腱生蛋白C)以及四种传统肿瘤标志物(CA 19-9、TPS、CEA和Ca 125)的组织表达和循环水平。

方法

采用免疫荧光法分析正常胰腺组织和胰腺导管腺癌组织中标志物的表达。在手术前后测定标志物的血浆浓度。以非恶性疾病患者作为对照。

结果

传统标志物和基质衍生物质分别在癌细胞区室和基质中表达。尽管大多数患者在手术前多种标志物水平升高,但在此阶段有2/12(17%)的患者Ca 19-9水平正常。术前内皮抑素/ XVIII型胶原水平高以及术后IV型胶原水平高与生存期短相关。TPS、Ca 125或CA 19-9的术前和术后水平均与生存期无关。

结论

胰腺导管腺癌的特征是富含基质。这些初步观察结果表明,基质可能是胰腺导管腺癌肿瘤标志物的来源,这些标志物存在于癌症的不同区室中,从而反映肿瘤生物学的不同方面。

相似文献

1
Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinoma.联合使用传统和基质来源的肿瘤标志物诊断胰腺导管腺癌
Cancer Biomark. 2015;15(1):1-10. doi: 10.3233/CBM-140430.
2
Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.Sineoculis homeobox homolog 1 蛋白过表达可作为胰腺导管腺癌的独立生物标志物。
Exp Mol Pathol. 2014 Feb;96(1):54-60. doi: 10.1016/j.yexmp.2013.11.003. Epub 2013 Nov 18.
3
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.术前 CEA 和 CA 19-9 是可切除性胰腺导管腺癌患者生存的预后标志物——一项回顾性肿瘤标志物预后研究。
Int J Surg. 2013;11(10):1067-72. doi: 10.1016/j.ijsu.2013.10.005. Epub 2013 Oct 23.
4
Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.埃兹蛋白过表达预示胰腺导管腺癌预后不良。
Exp Mol Pathol. 2015 Feb;98(1):1-6. doi: 10.1016/j.yexmp.2014.11.003. Epub 2014 Nov 5.
5
Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.用于检测胰腺导管腺癌生物标志物的比较蛋白质组学分析。
J Clin Pathol. 2008 Jan;61(1):49-58. doi: 10.1136/jcp.2006.044735. Epub 2007 Apr 5.
6
Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.胰腺癌中肌腱蛋白C、纤连蛋白与肿瘤-基质比值
Pancreas. 2019 Jan;48(1):43-48. doi: 10.1097/MPA.0000000000001195.
7
Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.胰腺导管腺癌及对照患者的无细胞血浆 microRNA。
Pancreas. 2013 Oct;42(7):1107-13. doi: 10.1097/MPA.0b013e318296bb34.
8
The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.激活的基质指数是胰腺导管腺癌中一种新型的独立预后标志物。
Clin Gastroenterol Hepatol. 2008 Oct;6(10):1155-61. doi: 10.1016/j.cgh.2008.05.006. Epub 2008 Jul 17.
9
Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC.基质调节的HMGA2是胰腺导管腺癌和阑尾腺癌中的一个独立预后标志物。
Br J Cancer. 2017 Jun 27;117(1):65-77. doi: 10.1038/bjc.2017.140. Epub 2017 May 18.
10
Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.IGFBP7 低表达与胰腺导管腺癌不良预后相关。
Ann Surg Oncol. 2012 Nov;19(12):3971-8. doi: 10.1245/s10434-012-2407-2. Epub 2012 May 24.

引用本文的文献

1
A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma.液体活检作为胰腺导管腺癌诊断、预后和预测生物标志物的潜在作用的全面综述。
Cells. 2023 Dec 19;13(1):3. doi: 10.3390/cells13010003.
2
A Cross-Sectional and Longitudinal Analysis of Pre-Diagnostic Blood Plasma Biomarkers for Early Detection of Pancreatic Cancer.用于胰腺癌早期检测的预诊断血浆生物标志物的横断面和纵向分析。
Int J Mol Sci. 2022 Oct 26;23(21):12969. doi: 10.3390/ijms232112969.
3
Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment.
癌症进展过程中的胶原重塑为癌症诊断和治疗提供了新的机会。
Int J Mol Sci. 2022 Sep 10;23(18):10509. doi: 10.3390/ijms231810509.
4
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits.靶向胰腺癌中的肿瘤-基质相互作用:胶原蛋白和机械特性的影响
Front Cell Dev Biol. 2021 Nov 25;9:787485. doi: 10.3389/fcell.2021.787485. eCollection 2021.
5
Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples.诊断前胰腺癌样本中的循环组织多肽特异性抗原
Cancers (Basel). 2021 Oct 23;13(21):5321. doi: 10.3390/cancers13215321.
6
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?细胞外基质与癌症相关成纤维细胞:癌症诊断与治疗的靶点?
Cancers (Basel). 2021 Jul 11;13(14):3466. doi: 10.3390/cancers13143466.
7
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer.胰腺癌诊断、预后及预测生物标志物的最新发现
Cancers (Basel). 2020 Nov 2;12(11):3234. doi: 10.3390/cancers12113234.
8
Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma.血清骨涎蛋白(BSP)水平升高可预测胰腺腺癌患者的长期死亡率。
Sci Rep. 2019 Feb 6;9(1):1489. doi: 10.1038/s41598-018-38352-2.
9
Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors.肿瘤细胞外基质重塑:作为实体瘤诊断和预后的循环工具的新视角。
Cells. 2019 Jan 23;8(2):81. doi: 10.3390/cells8020081.
10
Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancer.胰腺癌中 CD44-基质配体网络内的新型预后标志物。
J Pathol Clin Res. 2019 Apr;5(2):130-141. doi: 10.1002/cjp2.122. Epub 2018 Dec 13.